Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
10/2009
10/28/2009CN100553636C Method of using diketopiperazines and composition containing them
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009CA2506441C 5-substituted-pyrazine or pyridine glucokinase activators
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/27/2009CA2419665C Novel 2-phenylpiperazine derivatives
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/22/2009US20090264435 Novel Aryl- and Heteroarylpiperazines
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264416 N-benzyl,n'-arylcarbonylpiperazine derivatives
10/22/2009US20090264336 glucokinase activator 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide or a salt ; deprotecting silanol group with an acid; type 2 diabetes
10/22/2009US20090264315 Dipeptide mimics, libraries combining two dipeptide mimics with a third group, and methods for production thereof
10/21/2009EP2109602A2 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
10/21/2009EP1979320B1 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/21/2009EP1608374B9 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/21/2009CN101563330A Benzoyl amino heterocyclyl compounds as glucokinase (GLK) activators
10/21/2009CN101563329A Novel method for producing 4,4'-(1-methyl-1,2-ethanediyl)-bis-(2,6-piperazinedione)
10/20/2009US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/20/2009US7605260 Process for producing imide compound
10/20/2009US7605259 Structurally rigid dopamine d3 receptor selective ligands and process for making them
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7605163 Benzoyl-piperazine derivatives
10/20/2009US7605161 Pyridyl derivatives and their use as therapeutic agents
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/15/2009WO2009126123A1 Bicyclic nitrogen containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
10/15/2009US20090259030 Stabilized nucleic acid dark quencher-fluorophore probes
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009CA2720530A1 Sulfonamides
10/15/2009CA2719650A1 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
10/14/2009CN101558507A Material for organic electroluminescent device and organic electroluminescent device
10/14/2009CN100548300C Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
10/13/2009US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601751 N-(4-{N'-[2-(6-Bromo-1H-indol-3-yl)-acetyl]-guanidinomethyl}-2,6-dichloro-phenyl)-acetamide, for example; useful in the treatment of neurological disorders related to beta-amyloid production, particularly, treatment of Alzheimer's Disease and similar diseases
10/13/2009US7601715 HIV inhibitors
10/13/2009US7601674 α-oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
10/13/2009US7601435 Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same
10/13/2009CA2429844C Mch antagonists and their use in the treatment of obesity
10/08/2009WO2009124150A2 Stabilized nucleic acid dark quencher-fluorophore probes
10/08/2009WO2009123714A2 Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
10/08/2009WO2009121741A1 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/08/2009WO2009089234A3 Substituted dibenzhydrylpiperazines
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253905 Process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content
10/08/2009US20090253713 Small Molecule Compositions for Sexual Dysfunction
10/08/2009US20090253710 NMDA Receptor Antagonists for Neuroprotection
10/08/2009US20090253707 Heteroannelated anthraquinone derivatives and the synthesis method thereof
10/08/2009CA2720511A1 Stabilized nucleic acid dark quencher-fluorophore probes
10/08/2009CA2718645A1 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/06/2009US7598423 e.g. 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
10/06/2009US7598391 Heteroaryl-ureas and their use as glucokinase activators
10/06/2009US7598386 Sulphones which modulate the action of gamma-secretase
10/06/2009US7598272 Kinase inhibitors
10/06/2009US7598251 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
10/06/2009US7598249 4-(3,4-dibromo-benzyl)-piperazine-1-carboxylic acid pyridin-3-ylamide; fatty acid amide hydrolase (FAAH) activity; anxiety, pain, inflammation, sleep disorders, eating disorders, or movement disorders such as multiple sclerosis
10/06/2009US7598241 Carboxamide derivatives and their use as factor Xa inhibitors
10/06/2009US7598236 Diazabicyclic central nervous system active agents
10/06/2009CA2291048C Dehydration plant
10/01/2009WO2009095399A3 Pyrazine derivatives and their use as protein kinase inhbitors
10/01/2009US20090247731 Boronic ester and acid compounds, synthesis and uses
10/01/2009US20090247550 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/01/2009US20090247533 Ecteinascidins
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247506 Antibacterial agents
10/01/2009US20090243476 Acenaphthoquinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device
10/01/2009US20090242837 Charge transport compositions and electronic devices made with such compositions
09/2009
09/30/2009EP2105435A1 Hydrazone derivative
09/30/2009CN101544610A Ligustrazine salt
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595359 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
09/29/2009US7595344 Sulphones which modulate the action of gamma secretase
09/29/2009US7595336 Isatine derivatives with neurotrophic activity
09/29/2009US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example
09/29/2009US7595319 Compounds having selective inhibiting effect at GSK3
09/24/2009WO2009115517A2 Organic compounds
09/24/2009WO2009076618A3 Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins
09/24/2009US20090240052 Novel anthranilic acid derivative or salt thereof
09/24/2009US20090239848 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
09/24/2009US20090239841 Diaryl Ureas as CB1 Antagonists
09/24/2009US20090238761 Novel Aryl Piperazine Derivatives With Medical Utility
09/24/2009CA2718526A1 Organic compounds
09/23/2009EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/23/2009CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
09/23/2009CN101538249A Preparation method of tritium or deuterium-labeled cyadox
09/23/2009CN101538248A Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device using the same
09/23/2009CN100543016C Intermediate compound of 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives
09/22/2009US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability
09/22/2009US7592340 Quinoxalines useful as inhibitors of protein kinases
09/22/2009US7592337 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
09/17/2009WO2009113677A1 A low-corrosion ion liquid and a lubricating oil composition including same
09/17/2009WO2009112691A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
09/17/2009WO2009112523A1 Substituted pyraz inylmethyl sulfonamides for use as. fungicides
09/17/2009US20090234120 Ionic Liquids
09/17/2009US20090233944 Pyrazine-2-carboxyamide derivatives
09/17/2009US20090233909 Sulfonamide compounds as cysteine protease inhibitors
09/17/2009CA2713367A1 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
09/16/2009EP2099774A1 Inhibitors of kinase activity
09/16/2009EP2099773A1 Novel method for producing 4,4'-(1-methyl-1,2-ethanediyl)-bis-(2,6-piperazinedione)
09/16/2009EP2099769A1 6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases
09/16/2009EP2099768A2 Agonists of the sphingosine-1-phosphate receptor
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 187